This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Padavala, S. Articles by Crocker, I. Search for Related Content PubMed PubMed Citation Articles by Padavala, S. Articles by Pope, N. Articles by Beker, P. Articles by Crocker, I. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Risk Pregnancy Pregnancy Hazardous Substances DB OXYGEN Social Bookmarking                         What's this?

An Imbalance Between Vascular Endothelial Growth Factor and its Soluble Receptor in Placental Villous Explants of Intrauterine Growth-Restricted Pregnancies

Nicole Pope, MBBS

Philip Beker, DM

Maternal and Fetal Health Research Centre, St. Mary's Hospital, Manchester, United Kingdom; The Royal Hallamshire Hospital, Sheffield, United Kingdom

Ian Crocker, PhD

Maternal and Fetal Health Research Centre, St. Mary's Hospital, Manchester, United Kingdom; The Royal Hallamshire Hospital, Sheffield, United Kingdom Ian.Crocker{at}manchester.ac.uk

Objectives: Human umbilical vascular endothelial cells (HUVECs), seeded on Matrigel (BD Biosciences, Bedford, UK), undergo an angiogenic-like process. WE Hypothesized that placental explants from normal pregnancies, maintained in cultures of different oxygen, would liberate factors that could be measured in this system. We furhter tested the angiogenic potential of placentae from intrauterine growth-restricted (IUGR) pregnancies and the effects of vascular endothelial growth factor (VEGF) blockade.

Methods: Placental villos explants were maintained in culture at 3% and 20% O₂. The resultant media was added to HUVECs seeded on 80% Matrigel. Cells were incubated at 6% O₂ in accordance with the natural placental environment. After 6 hours, cells were fixed and stained and the length and number of tubules measured by morphometric imaging. Finally, VEGF and soluble VEGF receptor (sVEGFR-1) were recorded in the explant conditioned media.

Results: Within the angiogenic assay, recombinant human VEGF significantly enhanced tubule outgrowth (branching and elongation) and this effect was effect was blocked with neutralising antibody. Compare do 20% O₂, media of placental explants conditioned at 3% O₂ significantly encouraged tubule length and numbers. Again this affect was ablated by VEGF blockade. In cases of IUGR, conditioned media at #% O₂ showed a significant reduction in tubule growth. This was paralleled by a decline in available VEGF brought about an exaggeration in liberated sVEGRF-1. Notably, venous cord serum from IUGR pregnancies showed a similar elevation in sVEGGR-1.

Conclusion: Under restricted oxygen, placental angiogenic potential is suppressed in IUGR pregnancies through the overproduction of placental sVEGFR-1. This reduction may discourage normal placental vascularization and impact on fetal development.

Key Words: Placenta • angiogenesis • intrauterine growth restriction • vascular endothelial growth factor • soluble vascular endothelial grtowh factor receptor

References

• 1. Kaufmann P, Mayhew TM, Charnock-Jones DS. Aspects of human fetoplacental vasculogenesis and angiogenesis. II. Changes during normal pregancy. Placenta 2004;25:114-126.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 2. Mayhew TM, Wijesekara J, Baker PN, Ong SS. Morphometric evidence that villous development and fetoplacental angiogenesis are compromised by intrauterine growth restriction but not by pre-eclampsia. Placenta 2004;25:829-833.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 3. Daayana SL, Baker PN, Crocker IP. An image analysis technique for the investigation of variations in placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. J Soc Gynecol Invest 2004;11:545-552.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 4. Ahmed A, Perkins J. Angiogenesis and intrauterine growth restriction. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:981-998.[CrossRef][Medline] [Order article via Infotrieve]
• 5. Kingdom JC, Kaufmann P. Oxygen and placental vascular development. Adv Exp Med Biol 1999;474:259-275.[Web of Science][Medline] [Order article via Infotrieve]
• 6. Ong S, Lash G, Baker PN. Angiogenesis and placental grwoth in normal and compromised pregnancies. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:969-980.[CrossRef][Medline] [Order article via Infotrieve]
• 7. Lash GE, Taylor CM, Trew AJ, et al. Vascular endothelial growth factor and placental growth factor release in cultured trophoblast cells under different oxygen tensions. Growth Factors 2002;20:189-196.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 8. Clark DE, Smith SK, Licence D, Evans AL, Charnock-Jones DS. Comparison of expression patterns for placenta growth factor, vacular endothelial growth factor (VEGF), VEGF-B and VEFG-C in the human placenta throughout gestation. J Endocrinol 1998;159:459-467.[Abstract]
• 9. Helske S, Vuorela P, Carpen O, Hornig C, Weich H, Halmesmaki E. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placents from normal and complicated pregnancies. Mol Hum Reprod 2001;7:205-210.[Abstract/Free Full Text]
• 10. Ferrara N, Houck K, Jakeman L, Leung DW. amolecular and biological properties of the vascular endothelial growht factor family of proteins. Endocr Rev 1992;13:18-32.[Abstract/Free Full Text]
• 11. Geva E, Giniznger DG, Zaloudek CJ, Moore DH, Byrne A, Jaffe RB. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. J Clin Endocrinol Metab 2002;87:4213-4224.[Abstract/Free Full Text]
• 12. Wilcok MA, Johnson IR, Maynard PV, Smith SJ, Chilvers CE. The individualised birthweight ratio: A more logical outcome measure of pregnancy than birthweight alone. Br J Obstet Gynaecol 1993;100:342-347.[Web of Science][Medline] [Order article via Infotrieve]
• 13. Crocker IP, Tansinda DM, Jones CJ, Baker PN. The influence of oxygen and tumor necrosis factor-alpha on the cellular kinetics of term placental villous explants in culture. J Histochem Cytochem 2004;52:749-757.[Abstract/Free Full Text]
• 14. Soothill PW, Nicolaides KH, Rodeck CH, Cambell S. Effect of gestational age on fetal and intervillous blood gas and acid-base values in human pregnancy. Fetal Ther 1986;1:168-175.[Medline] [Order article via Infotrieve]
• 15. Fujikura T, Yoshida J. Blood gas analysis of placental and uterine blood during cesarean delivery. Obstet Gynecol 1996;87:133-136.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 16. Hung TH, Skepper JN, Burton GJ. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 2001;159:1031-1043.[Abstract/Free Full Text]
• 17. Jauniaux E, Hempstock, J, Greenwold N, Burton GJ. Trophoblastic oxidative stress in relation to temporal and regional differences in maternal placental blood flow in normal and abnormal early pregnancies. Am J Pathol 2003;162:115-125.[Abstract/Free Full Text]
• 18. Kim KJ, Li B Houck K, Winer J, Ferrara N. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 1992;7:53-64.[Medline] [Order article via Infotrieve]
• 19. Brockelsby J, Hayman R, Ahmed A, Warren A, Johnson I, Baker P. VEGF via VEGF receptor-1 (Flt-1) mimics preeclamptic plasma in inhibiting uterine blood vessel relaxation in pregnancy: Implications in the pathogenesis of preeclampsia. Lab Invest 1999;79:1101-1111.[Web of Science][Medline] [Order article via Infotrieve]
• 20. Donovan D, Brown NJ, Bishop ET, Lewis CE. Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo. Angiogenesis 2001;4:113-121.[CrossRef][Medline] [Order article via Infotrieve]
• 21. Jelkmann W. Pitfalls in the measurement of circulating vascular endothelial growth factor. Clin Chem 2001;47:617-623.[Abstract/Free Full Text]
• 22. Davis GE, Camarillo CW. REgulation of endothelial cell morphogenesis by integrins, mechanical forces, and matrix guidance pathways. Exp Cell Res 1995;216:113-123.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 23. Kronenwett R, Graf T, Nedbal W, et al. Inhibition of angiogenesis in vitro by alphav integrin-directed antisense oligonucleotides. Cancer Gene Ther 2002;9:587-596.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 24. Baatout S, Cheta N. Matrigel: A useful tool to study endothelial differentiation. Rom J Intern Med 1996;34:263-269.[Medline] [Order article via Infotrieve]
• 25. Hadley MA, Weeks BS, Kleinman HK, Dym M. Laminin promotes formation of cord-like structures by Sertoli cells in vitro. Dev Biol 1990;140:318-327.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 26. Nicosia RF, Bonanno E, Smith M, Yurchenco P. Modulation of angiogenesis in vitro by laminin-entactin complex. Dev Biol 1994;164:197-206.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 27. Macara L, Kingdom JC, Kaufmann P, et Structural analysis of placental terminal villi from growth-restricted pregnancies with abnormal umbilical artery Doppler waveforms. Placenta 1996;17:37-48.[Web of Science][Medline] [Order article via Infotrieve]
• 28. Lee MJ, Ma YLaChapelle L, Kadner SS, Guller S. Glucocorticoid enhances transforming growth factor-beta effects on extracellular matrix protein expression in human placental mesenchymal cells. Biol Reprod 2004;70:1246-1252.[Abstract/Free Full Text]
• 29. Chen CP, Yang YC, Su TH, Chen CY, Aplin JD. Hypoxia and TGF-beta 1 act independently to increase extracellular matrix production by placental fibroblasts. J Clin Endocrinol Metab 2005;90:1083-1090.[Abstract/Free Full Text]
• 30. Michiels C, Minet E, Michel G, Mottet D, Piret JP, Raes M. HIF-1 and AP-1 cooperate to increase gene expression in hypoxia: role of MAP kinases. IUBMB Life 2001;52:49-53.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 31. Choi KS, Bae MK, Jeong JW, Moon HE, Kim KW. Hypoxiainduced angiogenesis during carcinogenesis. J Biochem Mol Biol 2003;36:120-127.[Web of Science][Medline] [Order article via Infotrieve]
• 32. Yang W, Ahn H, Hinrichs M, Torry RJ, Torry DS. Evidence of a novel isoform of placenta growth factor (PIGE-4) expressed in human trophoblast and endothelial cells. J Reprod Immunol 2003;60:53-60.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 33. Cai J, Ahmad S, Jiang WG, et al. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells. Diabetes 2003;52:2959-2968.[Abstract/Free Full Text]
• 34. Jackson MR, Carney EW, Lye SJ, Ritchie JW. Localization of two angiogenic growth factors (PDECGF and VEGF) in human placentae throughout gestation. Placenta 1994;15:341-353.[Web of Science][Medline] [Order article via Infotrieve]
• 35. Mayhew TM, Charnock-Jones DS, Kaufmann P. Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies. Placenta 2004;25:127-139.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 36. Kendall RL, Wang G, Thomas KA. Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun 1996;226:324-328.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 37. Ahmed A, Dunk C, Ahmad S, Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PIGF) and soluble Flt-1 by oxygen—A review. Placenta 2000;21 Suppl A:S16-S24.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• 38. Clark DE, Smith SK, He Y, et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation. Biol Reprod 1998;59:1540-1548.[Abstract/Free Full Text]

Journal of the Society for Gynecologic Investigation, Vol. 13, No. 1, 40-47 (2006)
DOI: 10.1016/j.jsgi.2005.09.010


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Free Full Text (Free PDF) Free Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Padavala, S. Articles by Crocker, I. Search for Related Content PubMed PubMed Citation Articles by Padavala, S. Articles by Pope, N. Articles by Beker, P. Articles by Crocker, I. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Risk Pregnancy Pregnancy Hazardous Substances DB OXYGEN Social Bookmarking                         What's this?